Theriva Biologics Inc (AMEX: TOVX) kicked off on Monday, up 6.90% from the previous trading day, before settling in for the closing price of $0.22. Over the past 52 weeks, TOVX has traded in a range of $0.20-$2.08.
During the last 5-year period, the sales growth of Healthcare Sector giant was 39.99%. While this was happening, its average annual earnings per share was recorded 80.61%. With a float of $32.97 million, this company’s outstanding shares have now reached $33.74 million.
Theriva Biologics Inc (TOVX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Theriva Biologics Inc is 2.27%, while institutional ownership is 1.30%.
Theriva Biologics Inc (TOVX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -11.49 earnings per share (EPS), lower than consensus estimate (set at -7.22) by -4.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.81% during the next five years compared to 39.99% growth over the previous five years of trading.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
Take a look at Theriva Biologics Inc’s (TOVX) current performance indicators. Last quarter, stock had a quick ratio of 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.54, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.28 in one year’s time.
Technical Analysis of Theriva Biologics Inc (TOVX)
Looking closely at Theriva Biologics Inc (AMEX: TOVX), its last 5-days average volume was 2.59 million, which is a drop from its year-to-date volume of 4.73 million. As of the previous 9 days, the stock’s Stochastic %D was 18.93%.
During the past 100 days, Theriva Biologics Inc’s (TOVX) raw stochastic average was set at 4.52%, which indicates a significant decrease from 29.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0238 in the past 14 days, which was lower than the 0.0433 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3606, while its 200-day Moving Average is $0.6949. However, in the short run, Theriva Biologics Inc’s stock first resistance to watch stands at $0.2470. Second resistance stands at $0.2630. The third major resistance level sits at $0.2815. If the price goes on to break the first support level at $0.2125, it is likely to go to the next support level at $0.1940. Now, if the price goes above the second support level, the third support stands at $0.1780.
Theriva Biologics Inc (AMEX: TOVX) Key Stats
The company with the Market Capitalisation of 7.79 million has total of 33,740K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -25,650 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -4,360 K.
